Scil Technology assets bought out by Nanohale
This article was originally published in Scrip
Executive Summary
Nanohale, a German firm developing new formulations of protein and peptide therapeutics, has acquired the R&D and contract development and manufacturing services assets of Scil Technology, bringing them into a new wholly owned subsidiary called Formycon.